CEMAG Care mission is to answer patients’ medical needs by developing and commercializing innovative medical devices and drugs by allowing access of these treatments to populations in need.
To achieve this mission, we foster innovative healthcare research projects into viable commercial products (drugs, medtech, biotech) and bring them to patients. Our motivation is to answer meaningful unmet medical needs and bring to all patients the care they deserve.
Fort de son expérience dans le domaine du dispositif médical de diagnostic in-vitro et de sa structure d’établissement pharmaceutique, CEMAG Care distribue le test de détection COVID-19 anticorps IgM/IgG du laboratoire canadien Artron Laboratories Inc, combiné à l’application mobile/web iSTOC IDA One.
Pour toute commande ou demande de renseignement, vous pouvez nous contacter par téléphone au 01 58 28 16 83 ou par mail à l’adresse suivante : serviceclient@cemagcare.com
Development and commercialization of healthcare innovation:
Fostering the development and the commercialization of healthcare innovations such as medical devices or in vitro diagnostics
Specific activity toward Non-For-Profit Organizations to facilitate medical product accessibility to population in need
Pharmaceutical operations of various pharmaceutical products in France (“Exploitant Pharmaceutique”, MAH) and other European countries:
> Market Authorization Holder and distribution of pharmaceutical products
> Regulatory (submissions, applications and regulatory Life Cycle Management activities….)
> Medical Affairs (pharmacovigilance, medical information, clinical studies, scientific advice, Literature reviews, medical writing…)
> Service activities for third parties for regulatory strategy and registration in Europe
> A senior team with high expertise and a history of success stories
> Exploitant of Marketing Authorisations in France
In compliance with article L.5121-1-3 of French Public Health Code (Code de la Santé Publique), please find below the list of all active substances of drug products exploited by Cemag Care :
LIST OF DRUG PRODUCTS EXPLOITED BY CEMAG CARE
For medical information request or pharmacovigilance, please contact pharmacovigilance@cemagcare.com
Découvrez toutes les consignes de tri et les lieux de collecte près de chez vous sur www.consignesdetri.fr.
> Product development in accordance with ISO13485: from initial patient needs to breakthrough medical solutions.
> Fostering our own projects of medical devices
> Providing service activities to help the development of innovative medical solutions (from Proof of Concept Studies to Market authorization
> Materiovigilance
> An expertized team focused on innovation for patients
In healthcare, all patients are entitled to all approved products with the highest quality standards.
> Facilitating relationship between For-Profit Healthcare industry and Non-For-Profit Organizations, to allow :
> Populations in needs to access healthcare products
> Healthcare companies to develop new markets and increase their product volumes
> Supplier for Pharma industries dedicated to Non-For-Profit and Public markets (handling of tenders, agreements, logistics)
> Strong network with Non-For-Profit Organizations
ANDRÉ ULMANN
MD, PhD
Founder
and CEO
JEAN-FRANCOIS LE MEUR
Regulatory Affairs Specialist
STÉPHANIE LE CORRE
Quality Affairs Manager
MAÏA ALEXALINE – PhD
Scientific Director
ANAÏS CASTIGLIA
Marketing Manager
VICTORIA MICHAELS LOPEZ
PhD
Project Manager
CLÉMENCE DESJARDIN – PhD
Project Manager
MANON EXPOSITO – Pharm.D.
Pharmaceutical Affairs Director
QPPV
Qualified Person
MARIE CROIZAT – Pharm.D.
Regulatory Affairs Director
PATRICK GAUDE – Pharm.D.
Technical Director
AMEL ABBES
Office Manager
Dermatology & Wound care
> Women’s health (innovative fertility regulation methods)
> Diagnostics
> Emergency healthcare (e.g. bioterrorism)
> Orphan diseases
> Addiction
May 2020
Due to the increasing need for reliable detection tests of covid19 infection, CEMAG Care is working on distributing a CE-mark rapid test detecting SARS-CoV-2 IgG/IgM antibodies which will be available in the coming weeks.
March 2019
Cemag Care is MAH of CURETHYL 26 POUR CENT, solution injectable I.V, CALPRIMUM 500 mg, comprimé enrobé à croquer, and ASCOFER 33 mg, gélule
March 2017
André Ulmann’s book « Le combat d’un médecin pour les femmes » has just been published (French edition only for the moment).
